PLOS IMAGE: SU/ ÖSTRA: INSIDE BY NIGHT CREDIT: MESCON, FLICKR (CC BY 2.0, HTTPS://CREATIVECOMMONS.ORG/LICENSES/BY/2.0/) Among patients with chronic, non-communicable diseases, the risk of death is more than doubled if they also have a psychiatric comorbidity, according to a new study publishing January 27th in PLOS Medicine by Seena Fazel of the University of Oxford, UK, and colleagues. Non-communicable diseases...
by Monash University Increased concentration of short-chain fatty acids in stool and plasma following HAMSAB supplementation. A Acetate, propionate, and butyrate concentrations in stool (mM) and B plasma (μM). Overall significance determined by GEE and pairwise differences between timepoints by estimated marginal means and include a Tukey adjustment for multiple corrections. Colors indicate individual subjects....
Zarrin Hossain January 05, 2022 Type 2 diabetes (T2D) is associated with a number of risk factors and now new research, published in Diabetes Care, suggests that increased levels of liver fat and a smaller pancreas volume may also add to a greater risk of developing T2D. Head of Research Communications at Diabetes UK, Dr. Lucy Chambers, commented that this breakthrough...
by Baker Heart and Diabetes Institute Myocardial Infarction or Heart Attack. Credit: Blausen Medical Communications/Wikipedia/CC-A 3.0 A new study by researchers at the Baker Heart and Diabetes Institute and Monash University could help inform treatment and prevent serious events like a heart attack or death in diabetic patients at high risk of serious cardiovascular events....
In a person with type 1 diabetes, the body mistakenly attacks pancreatic cells that produce insulin, a hormone responsible for regulating blood sugar. Without insulin, serious and eventually fatal symptoms will occur. Yet, imagine if, instead of needing daily insulin injections, people with diabetes could have insulin-producing cells placed back into the body, fixing the problem...
by Harvard T.H. Chan School of Public Health Credit: Unsplash/CC0 Public Domain A newly discovered hormone named fabkin helps regulate metabolism and may play an important role in the development of both type 1 and type 2 diabetes, according to research led by the Sabri Ülker Center for Metabolic Research at Harvard T.H. Chan School of...
by Melissa Rohman, Northwestern University Effects of dapagliflozin on selected secondary endpoints and in supportive responder analysis. a–c, Effects of dapagliflozin on selected secondary endpoints and in supportive responder analysis. Effects of dapagliflozin versus placebo at 12 weeks on 6MWT distance (a), KCCQ-CS responder analysis (b) and KCCQ-OS (c). Data are presented as mean values with 95%...
By Nick Lavars A new study has shown how insulin resistance in diabetes could be tackled through experimental senolytic drugs that target zombie-like cellsUgreen/Depositphotos VIEW 1 IMAGES Zombie-like cells that have stopped dividing in the human body and accumulate as we age, known as senescent cells, continue to find themselves at the center of all kinds of...
by Boston University School of Medicine Three-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli, Ph.D., and Karen Meaburn, Ph.D. at the NIH IRP. Obesity, insulin resistance and Type 2 diabetes are risk factors for breast cancer...
by University of Connecticut Credit: CC0 Public Domain Eliminating old, dysfunctional cells in human fat also alleviates signs of diabetes, researchers from UConn Health report. The discovery could lead to new treatments for Type 2 diabetes and other metabolic diseases. The cells in your body are constantly renewing themselves, with older cells aging and dying as...
